Duke Adult Sickle Cell Program is a clinical research site located in Durham, North Carolina, United States 27710.
Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.
Duke Adult Sickle Cell Program has participated in 1 clinical trials.
Therapeutic areas: Sickle Cell Disease, COVID-19 Vaccine, Vaccine Hesitancy.
Sponsors: Duke University.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in North Carolina · View every site in Durham
Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Duke Adult Sickle Cell Program has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Duke Adult Sickle Cell Program has 1 clinical trials on record. Their work covers Sickle Cell Disease, COVID-19 Vaccine, Vaccine Hesitancy.
Duke Adult Sickle Cell Program has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.